ACSL5 and metabolic dysfunction-associated steatotic liver disease: Interestingly, Houet al. [2] found that the cytoplasmic SIRT6–ACSL5 axis serves as a protective mechanism to counter NAFLD pathological changes, preventing the progression from simple steatosis to NASH under metabolic stress by facilitating FAO and enhancing mitochondrial adaptation.